## CVX: Chevron Corporation - XLE: Energy

### Executive Summary

No thesis match: MRS_20 -3.5% below STRENGTH zone (4.0-10.0%); PEG 2.94 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.8% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($144.70)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. Chevron updates bylaws and executive team, adds new officer roles**
- Source: Investing.com | 20251205T230812 | Somewhat-Bullish | Relevance: 100%
- Chevron Corporation announced amendments to its bylaws to simplify officer roles and modernize titles, effective December 5, 2025. The company also updated its executive team, adding two new executive officers and adjusting titles to align with current industry practices. These changes are part of Chevron's effort to streamline corporate governance and enhance operational flexibility.

**2. Chevron sets 2026 capex at $18–$19 billion, prioritizes high-return upstream growth**
- Source: Oil & Gas 360 | 20251205T185113 | Bullish | Relevance: 100%
- Chevron announced an organic capital expenditure range of $18–$19 billion for 2026, with a focus on disciplined spending, efficiency improvements, and high-return upstream development. The company plans to allocate approximately $17 billion to upstream activities, with over half of the total organic capex directed towards the United States for shale and tight oil developments. This strategy aims to expand cash flow and earnings while maintaining strategic flexibility and delivering superior shareholder returns.

**3. Chevron-operated Gorgon project secures $2 billion investment nod**
- Source: Reuters | 20251205T010438 | Somewhat-Bullish | Relevance: 100%
- The Australian unit of U.S. oil giant Chevron Corp announced a final investment decision for the A$3 billion ($1.98 billion) Gorgon Stage 3 development off Western Australia's northwest coast. This investment will connect the Geryon and Eurytion natural gas fields to Gorgon's existing infrastructure, maintaining production and ensuring long-term gas supply for Western Australia and LNG for international customers. The Gorgon Project is a joint venture primarily owned by the Australian units of Chevron, Exxon Mobil, and Shell.

**4. Chevron Expects 2026 Budget To Be on Lower End of Guidance**
- Source: Rigzone | 20251204T130849 | Somewhat-Bullish | Relevance: 100%
- Chevron projects its 2026 organic capital spending for consolidated subsidiaries to be $18-19 billion, at the lower end of its annual guidance. The company plans to dedicate over half of this capital expenditure to the United States, with a significant portion allocated to Permian, DJ, and Bakken shale assets, aiming for over two million barrels of oil equivalent per day in U.S. production. Additionally, Chevron emphasizes structural cost reductions and investments in lowering carbon intensity and new energies businesses.

**5. Chevron Expects 2026 Budget To Be on Lower End of Guidance**
- Source: Rigzone | 20251204T130231 | Somewhat-Bullish | Relevance: 100%
- Chevron Corp anticipates its 2026 organic capital spending to be at the lower end of its guidance, projecting $18-19 billion for consolidated subsidiaries. Over half of this, $10.5 billion, is allocated to the United States, with a significant portion targeting U.S. shale and tight assets. The company is also focused on growth in Guyana, Eastern Mediterranean, and the Gulf of America, and aims for $3-4 billion in structural cost reductions by the end of 2026.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 4, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-01 | HSBC | $169 | $166 | +2% |
| 2025-11-14 | Wells Fargo | $196 | $190 | +3% |
| 2025-11-13 | Piper Sandler | $168 | $169 | -1% |
| 2025-11-13 | Mizuho | $204 | $191 | +7% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-01 | HSBC | up | Buy |
| 2025-11-14 | Wells Fargo | main | Overweight |
| 2025-11-13 | Piper Sandler | main | Overweight |
| 2025-11-13 | Mizuho | main | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 4 ($0.86M) |
| Sells | 3 ($37.80M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 40.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 9 / 0 |

**Top Holders:**
- Vanguard Group Inc: 9.1% (+17.9%)
- State Street Corpora: 7.6% (+9.2%)
- Blackrock Inc.: 6.9% (+16.9%)
- Berkshire Hathaway, : 6.1% (0.0%)
- Geode Capital Manage: 2.2% (+18.0%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-2.8% 5d) with bearish MACD, trend may be turning.
2. Heavy insider selling: $38M sold (3 transactions in 90 days).
3. Valuation risk: PEG 2.9x with declining EPS estimates leaves no margin for error.

### Catalysts

- Analyst target momentum: 4 raises (avg +3%) could attract flows.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 2.94 signals overvaluation risk, limited margin of safety. Forward P/E 19.9x stretched relative to 3% growth. Balance sheet: $4.7B free cash flow. Insider selling cluster ($37.8M in 90 days), potential headwind. Institutional flow bullish (9 buying vs 0 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $302.3B |
| Beta | 0.67 |
| 52W Range | $132.04 - $168.96 |
| Short Interest | 0.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.94 |
| Forward P/E | 19.9 |
| Current P/E | 20.4 |
| YoY Growth | 2.9% |
| EPS Direction | FALLING |

### Technicals

MRS_20 deteriorating from -0.7% to -3.5% (-2.8% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 7.5pp (needs >4.0% for momentum thesis). Below SMA200 (0.99x), long-term trend not supportive. RSI neutral at 44. OFD pattern: -MTN (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -3.49% (CS: 24) | Weak |
| RSI_14 | 43.7 | Neutral |
| MACD Histogram | -0.02 | Bearish |
| vs SMA20 | 0.984x | Below |
| vs SMA50 | 0.978x | Below |
| vs SMA200 | 0.995x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $150.00
- **Stop Loss:** $144.70 (3.5% risk)
- **Target:** $155.30 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 94
- **Position Value:** $14,100.00
- **Portfolio %:** 14.10%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with balanced risk appetite. VIX near 15th percentile of 52-week range signals calm conditions, while modest yield curve steepening (54bps 10Y-3M) suggests healthy growth expectations. Breadth at 52% indicates selective participation rather than broad-based momentum.*

### Earnings

**Next:** 2026-01-30 (Est: $1.57)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.71 | $1.85 | +8.4% |
| 2025Q2 | $1.74 | $1.77 | +1.7% |
| 2025Q1 | $2.15 | $2.18 | +1.3% |
| 2024Q4 | $2.11 | $2.06 | -2.3% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*